Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
New polymer heart valve shows early potential | Cardiologist and war hero dies at 89 | Preterm births & ischemic heart disease
Tuesday, June 30, 2020
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Top Stories

New polymer heart valve could be a breakthrough for valve replacement surgery

The artificial valve would give clinicians a new option that lasts up to 25 years and does not require prescribing anticoagulation medications.

READ MORE >
heart valve
Share on Twitter Share on Facebook Share on Linkedin

New polymer heart valve could be a breakthrough for valve replacement surgery

Share on Twitter Share on Facebook Share on Linkedin
heart valve
The artificial valve would give clinicians a new option that lasts up to 25 years and does not require prescribing anticoagulation medications.
READ MORE >

Revascularization vs. therapy alone for stable ischemic heart disease: What data from 15K patients tell us

When patients have stable ischemic heart disease, two primary treatment options are revascularization followed by guideline-directed medical therapy (GDMT) or GDMT alone.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Revascularization vs. therapy alone for stable ischemic heart disease: What data from 15K patients tell us

Share on Twitter Share on Facebook Share on Linkedin
When patients have stable ischemic heart disease, two primary treatment options are revascularization followed by guideline-directed medical therapy (GDMT) or GDMT alone.
READ MORE >

Canadian cardiologist who was a childhood war hero dies at 89

Dwight I. Peretz, MD, had a long career in cardiology, but he also lived an unforgettable childhood, one that included delivering undercover messages in Japanese-occupied Shanghai.

READ MORE >
candle-2038736_960_720.jpg
Share on Twitter Share on Facebook Share on Linkedin

Canadian cardiologist who was a childhood war hero dies at 89

Share on Twitter Share on Facebook Share on Linkedin
candle-2038736_960_720.jpg
Dwight I. Peretz, MD, had a long career in cardiology, but he also lived an unforgettable childhood, one that included delivering undercover messages in Japanese-occupied Shanghai.
READ MORE >

Preterm births associated with increased risk of ischemic heart disease for the mother

The study's authors tracked data from more than 2 million women.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Preterm births associated with increased risk of ischemic heart disease for the mother

Share on Twitter Share on Facebook Share on Linkedin
The study's authors tracked data from more than 2 million women.
READ MORE >

Featured Articles

Statin use leads to lower death rates among COVID-19 patients

The study included data from nearly 14,000 COVID-19 patients.

READ MORE >
covid-19 coronavirus
Share on Twitter Share on Facebook Share on Linkedin

Statin use leads to lower death rates among COVID-19 patients

Share on Twitter Share on Facebook Share on Linkedin
covid-19 coronavirus
The study included data from nearly 14,000 COVID-19 patients.
READ MORE >

When demand outpaces supply: 4 key facts about the looming physician shortage

The United States is expected to experience a colossal physician shortage in the years ahead, and new research suggests it will be felt in a wide variety of specialties, including cardiology. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

When demand outpaces supply: 4 key facts about the looming physician shortage

Share on Twitter Share on Facebook Share on Linkedin
The United States is expected to experience a colossal physician shortage in the years ahead, and new research suggests it will be felt in a wide variety of specialties, including cardiology. 
READ MORE >

What cardiologists should know about MIPS participation and COVID-19

Cardiologists participating in MIPS in 2020 didn’t exactly plan on providing care during a global pandemic.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

What cardiologists should know about MIPS participation and COVID-19

Share on Twitter Share on Facebook Share on Linkedin
Cardiologists participating in MIPS in 2020 didn’t exactly plan on providing care during a global pandemic.
READ MORE >

In Other News

New open access journal will rapidly review COVID-19 research, debunk false information

MIT Press will oversee Rapid Reviews: COVID-19 and says its peer review process will only take days, compared to the standard month required for typical workflows.

READ MORE >
COVID-19 coronavirus
Share on Twitter Share on Facebook Share on Linkedin

New open access journal will rapidly review COVID-19 research, debunk false information

Share on Twitter Share on Facebook Share on Linkedin
COVID-19 coronavirus
MIT Press will oversee Rapid Reviews: COVID-19 and says its peer review process will only take days, compared to the standard month required for typical workflows.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

TAVR for moderate aortic stenosis | BP drug recalled | Stroke prevention device fails | New Medicare cuts | CCTA-guided PCI
A new way to think about the heart health of women | GLP-1 drugs vs. metformin | Cannabis use may increase risk of CVD, stroke
New Medicare payment cuts | Telemedicine vs. in-person cardiology visits | FDA confirms Class I recall | Startup raises $160M
FDA approves transcatheter treatment for PVL | CCTA-guided PCI | Real-world RDN outcomes | J&J launches new IVL catheter
CCTA vs. IVUS for PCI guidance: Carlos Collet reviews the data | The real-world benefits of RDN | New TAVR tech falls short
TAVR Highlights: New data on treating moderate AS | CMS may expand coverage again | Is surgical backup still necessary?
GLP-1 drugs vs. metformin | BP drug recalled | The health risks of cannabis use | Energy drinks linked to heart issues
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme